Financials

  • Market Capitalization 227.08 M
  • Employee 228
  • Founded 2008
  • CEO N/A
  • Website www.karyopharm.com
  • Headquarter Delaware, United States
  • FIGI BBG001J272L7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.41
Relación precio/flujo de caja
0

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3555
NAUT
Nautilus Biotechnology, Inc. - Common Stock
1.76 USD-1.12%+4.14%-23.14%+128.57%223.66 M USD
3560
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.69 USD-3.40%-6.82%-10.44%+21.38%220.96 M USD
3564
CHRS
Coherus Oncology, Inc. - Common Stock
1.45 USD-1.36%-13.17%+1.40%-9.94%223.66 M USD
3565
AVXL
Anavex Life Sciences Corp. - Common Stock
2.45 USD+4.26%-9.59%-3.92%-78.51%227.05 M USD

Noticias